Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mehri Nikbin"'
Autor:
Esmaeel Mohammadi Pargoo, Mohammad Reza Aghasadeghi, Kazem Parivar, Mehri Nikbin, Pooneh Rahimi, Mehdi Shafiee Ardestani
Publikováno v:
IET Nanobiotechnology, Vol 15, Iss 7, Pp 627-637 (2021)
Abstract Infection with human immunodeficiency virus (HIV)‐1 causes immunological disorders and death worldwide which needs to be further assisted by novel anti‐retroviral drug delivery systems. Consequently, finding newer anti‐retroviral pharm
Externí odkaz:
https://doaj.org/article/2a967b4a3c8c47118a9088bb06af0075
Autor:
Heidar Sharafi, Seyed Hoda Alavian, Bita Behnava, Mohammad Saeid Rezaee-Zavareh, Mehri Nikbin, Seyed Moayed Alavian
Publikováno v:
Caspian Journal of Internal Medicine, Vol 11, Iss 1, Pp 41-46 (2020)
Background: Treatment of hepatitis C virus (HCV) infection with recently introduced direct-acting antiviral agents (DAA) is effective and safe, however there is little known regarding safety and efficacy of generic DAAs in the real-life clinical sett
Externí odkaz:
https://doaj.org/article/31c4eebb756742229dd58220ce3dc139
Autor:
Pooneh Rahimi, Kazem Parivar, Esmaeel Mohammadi Pargoo, Mohammad Reza Aghasadeghi, Mehdi Shafiee Ardestani, Mehri Nikbin
Publikováno v:
IET Nanobiotechnology
IET Nanobiotechnology, Vol 15, Iss 7, Pp 627-637 (2021)
IET Nanobiotechnology, Vol 15, Iss 7, Pp 627-637 (2021)
Infection with human immunodeficiency virus (HIV)‐1 causes immunological disorders and death worldwide which needs to be further assisted by novel anti‐retroviral drug delivery systems. Consequently, finding newer anti‐retroviral pharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ba9e06cc996a5a34aeff05f2711cf1
http://europepmc.org/articles/PMC8675833
http://europepmc.org/articles/PMC8675833
Autor:
Payam Tabarsi, Amir-Houshang Sharifi, Alireza Norouzi, Hossein Poustchi, Roya Sedghi, Shanaz Sali, Minoo Mohraz, Reza Malekzadeh, Jalal Karimi, Masoud Mardani, Saeed Kalantari, Dorsa Merat, Katayoun Tayeri, Seyed Ali Dehghan Manshadi, Shahin Merat, Mohammad-Hossein Somi, Zeinab Malekzadeh, Mehri Nikbin, Mehrnaz Rasoolinejad, Babak Mirminachi
Publikováno v:
International Journal of Clinical Practice. 75
Background: The current recommendation for treating hepatitis C virus (HCV) in HIV patients includes the combination of sofosbuvir (SOF) and daclatasvir (DCV). DCV should be used at different doses to compensate for interactions with antiretroviral t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d67b76607b531dd36363d1e6bfeec2f2
https://doi.org/10.1111/ijcp.14304
https://doi.org/10.1111/ijcp.14304
Autor:
Esmaeel Mohammadi, Pargoo, Mohammad Reza, Aghasadeghi, Kazem, Parivar, Azam, Bolhassani, Mehri, Nikbin, Pooneh, Rahimi, Mehdi Shafiee, Ardestani
Publikováno v:
Pakistan journal of pharmaceutical sciences. 33(2)
Human diseases like viral organisms for example, hepatitis, HIV and etc., attack the health and caused large mortality in populations by many years. So finding novel delivery vehicles based antiviral drugs employing nano-materials is of high universa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bab79f70b70c181a04defe838a35c10f
https://pubmed.ncbi.nlm.nih.gov/32276917
https://pubmed.ncbi.nlm.nih.gov/32276917
Publikováno v:
Medical Journal of the Islamic Republic of Iran
Background: Hepatitis C virus (HCV) infection is a cause of major liver complications, particularly in patients infected with human immunodeficiency virus (HIV). This study aimed to evaluate the efficacy of pegylated interferon (Peg-IFN) and a fixed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53639479a720eb5ddd34fb1d150bd86
https://pubmed.ncbi.nlm.nih.gov/31456987
https://pubmed.ncbi.nlm.nih.gov/31456987
Publikováno v:
Hepatitis Monthly. 17
Background: Hepatitis C virus (HCV), as a global health concern, has infected around 1.6% of the world population. Introduction of direct-acting antiviral regimens such as sofosbuvir/ledipasvir (SOF/LDV) made the treatment of HCV infection superior t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fc3121e3d1e5bc0daba29bbee56af46
https://doi.org/10.5812/hepatmon.12216
https://doi.org/10.5812/hepatmon.12216
Publikováno v:
Clinical Laboratory. 63
METHODS This case-control study, was performed on 136 blood samples based on 81 patients with chronic HCV genotypes 1 and 3 including 64 SVR positive and 17 negative and 55 healthy individual controls. DNA was isolated from the samples and the freque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210021f68643fad783d0d0e0c21b686a
https://doi.org/10.7754/clin.lab.2017.170308
https://doi.org/10.7754/clin.lab.2017.170308
Autor:
Mona Sadat, Larijani, Narges, Bahiraei, Mehri, Nikbin, Nasir, Mohajel, Leila Naghizadeh, Rad, Fahimeh, Baghbani, Maryam, Mapar, Seyed Mehdi, Sadat
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(8)
Infection with the hepatitis C virus is a major public health concern which can lead to carcinoma and liver failure. It has been shown that single nucleotide polymorphisms can affect the level of gene activity of tumor necrosis factor (TNF) which has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ec3f06a0425f54bb8d68f6db9128c9a
https://pubmed.ncbi.nlm.nih.gov/27644640
https://pubmed.ncbi.nlm.nih.gov/27644640
Autor:
Khashayar Hesamizadeh, Minoo Mohraz, Reza Malekzadeh, Ali Namvar, Mohammad Saeid Rezaee-Zavareh, Mahmood Nabavi, Hossein Poustchi, Seyed Moayed Alavian, Kamran Bagheri Lankarani, Massimo Colombo, Bijan Eghtesad, Mohamad Reza Fattahi, Bita Behnava, Masoud Mardani, Abdul Rahman Bizri, Behzad Hajarizadeh, Nasser Ebrahimi Daryani, Hatef Massoumi, Shahin Merat, Majid Amiri, Masood Ziaee, Mehri Nikbin, Peyman Adibi, Heidar Sharafi
Publikováno v:
Hepatitis Monthly
Context: Hepatitis C virus (HCV) infection is a major public health issue worldwide, including Iran. The new direct-acting antiviral agents (DAAs) with high efficacy have changed the landscape of HCV treatment. This guideline provides updated recomme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c1d72fc6f81aee1ad8d8b0826f4d3a
http://europepmc.org/articles/PMC5075356
http://europepmc.org/articles/PMC5075356